Publications by authors named "Masatoshi Yoshimoto"
We herein report a 69-year-old man with acute kidney injury who required dialysis after receiving a combination of three drug-induced lymphocyte stimulation test-positive drugs. A kidney biopsy showed tubulointerstitial nephritis with severe eosinophilic infiltration and numerous granuloma formations. Acute eosinophilic granulomatous tubulointerstitial nephritis was diagnosed.
View Article and Find Full Text PDFIntroduction: The DAPA-CKD study showed a protective effect of dapagliflozin on kidney function in chronic kidney disease (CKD) patients with and without diabetes mellitus. Although dapagliflozin is expected to be effective also in CKD patients with autosomal dominant polycystic kidney disease (ADPKD), its efficacy and safety in this population remain unknown because ADPKD was an exclusion criterion in the DAPA-CKD study. Therefore, we evaluated the effects of dapagliflozin in CKD patients with ADPKD.
View Article and Find Full Text PDFIntroduction: This study aimed to analyze the clinical course of TAFRO syndrome in patients through extended follow-up, focusing on recurrent cases and long-term remission.
Methods: This was a retrospective case series study. We assessed the clinical course of patients diagnosed with TAFRO syndrome between January 2012 and September 2022 at Toranomon Hospital or Toranomon Hospital Kajigaya, excluding those patients who died during the initial hospitalization.
Article Synopsis
- Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer with potential for extramedullary relapse (EMR), most commonly in the central nervous system, but can also occur in other organs like the kidneys.
- A 49-year-old man with Philadelphia chromosome-negative ALL developed a perirenal mass after a second umbilical cord blood transplant, which was diagnosed as EMR through a successful percutaneous biopsy performed while the patient was sitting.
- This case highlights a novel biopsy technique for renal lesions and emphasizes the importance of collaboration between hematologists and nephrologists in identifying EMR in patients with ALL.